AEZS-129, 131 and 132
Erk & PI3K inhibitors (oncology)

Therapeutic area

Oncology

Target indication

To come

Development stage

In vivo testing

Description

To come

Mode of action

To come

Trial results

To come

Development plan

To come

Partnership status

To come
Term and conditions of use. Safe harbor and privacy policy. Copyright © 2004 Æterna Zentaris Inc.
All rights reserved. Use of this site signifies your agreement to the terms of use.